Skip to main content

Table 5 Relation between TLG and histopathological criteria of tumor

From: Bronchogenic carcinoma: the added value of FDG PET/CT advanced volumetric and metabolic parameters in initial evaluation and their impact on prognosis and clinical outcome

  

TLG

Test value

P value

Mean

SD

Side

Right

376.93

205.19

2.40*

0.03

 

Left

135.20

147.67

  

Site

Upper lobe

272.40

206.87

1.67*

0.11

 

Middle/lower lobe

466.75

209.34

  

Histopathological grade

Grade 2

111.44a

93.00

36.56**

 < 0.001

 

Grade 3

485.33b

82.98

  
 

Grade 4

499.14b

107.73

  

Histopathology

Adenocarcinoma

328.50

217.51

0.69*

0.50

 

Other types

232.33

241.72

  

T staging

T1/T2

84.14

47.35

7.66*

 < 0.001

 

T3/T4

447.00

152.05

  

LN

Negative

183.56

176.87

2.95*

0.01

 

Positive

430.10

186.09

  

M staging

M0

216.27

195.06

2.63*

0.02

 

M1

446.75

178.63

  

Pathological stage

1a3

70.33a

32.99

13.07**

 < 0.001

 

3a

391.40b

153.21

  
 

4b

446.75b

178.63

  

Grade (cell diff)

Low (well differentiated)

75.50a

33.28

12.49**

0.001

 

Intermediate (moderately differentiated)

60.00a

42.43

  
 

High (poorly differentiated)

425.46b

164.99

  
  1. *Student's t-test **One-way ANOVA test (a,b: post hoc test)